Laird Norton Wetherby Trust Company’s Anixa Biosciences ANIX Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.62M	Buy	578,727 +12,400	+2%	+$34.5K	0.03%	388
2026 Q1	$1.46M	Sell	566,327 -21,700	-4%	-$64.3K	0.03%	388
2025 Q4	$1.83M	Sell	588,027 -9,208	-2%	-$37.7K	0.04%	341
2025 Q3	$1.97M	Sell	597,235 -20,000	-3%	-$63.3K	0.34%	39
2025 Q2	$2.04M	Sell	617,235 -5,000	-0.8%	-$14.3K	0.28%	37
2025 Q1	$1.78M	Hold	622,235	–	–	0.29%	37
2024 Q4	$1.44M	Buy	622,235 +1,500	+0.2%	+$4.66K	0.2%	41
2024 Q3	$1.96M	Buy	620,735 +16,500	+3%	+$50.7K	0.26%	38
2024 Q2	$1.34M	Hold	604,235	–	–	0.19%	39
2024 Q1	$1.89M	Buy	604,235 +235,400	+64%	+$939K	0.26%	43
2023 Q4	$1.43M	Buy	+368,835	New	+$1.24M	0.17%	46

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Laird Norton Wetherby Trust Company's ANIX Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company increased its Anixa Biosciences (ANIX) stake by 2.2% in Q2 2026, buying an estimated $34.5K and bringing the position to 578,727 shares worth $1.62M. The position accounts for 0.03% of the portfolio, ranked #388.

Laird Norton Wetherby Trust Company first reported a position in ANIX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.04M in Q2 2025. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

Laird Norton Wetherby Trust Company held 578,727 shares of Anixa Biosciences worth $1.62M as of Q2 2026.
Laird Norton Wetherby Trust Company bought 12,400 Anixa Biosciences shares in Q2 2026, an estimated $34.5K.
Anixa Biosciences made up 0.03% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #388 holding.
Laird Norton Wetherby Trust Company first reported a position in Anixa Biosciences in Q4 2023 and has held it in 11 quarters since.
Laird Norton Wetherby Trust Company's Anixa Biosciences position peaked at $2.04M in Q2 2025.
62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.